Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies

Infection and Immunity

Volumn 82, Issue 1, 2014, Pages 152-164

  Sony Reddy, K ^a   Pandey, Alok K ^a   Singh, Hina ^a   Sahar, Tajali ^a   Emmanuel, Amlabu ^a   Chitnis, Chetan E ^a   Chauhan, Virander S ^a   Gaur, Deepak ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; MALARIA VACCINE; NEUTRALIZING ANTIBODY; PROTEIN RH5; PROTOZOAL PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; ERYTHROCYTE; ESCHERICHIA COLI; GENETIC POLYMORPHISM; IMMUNOGENICITY; MALARIA; MEROZOITE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

EID: 84890825277     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00970-13     Document Type: Article

References (52)

1. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD. 2012. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379:413-431. http://dx.doi.org/10.1016/S0140-6736(12)60034-8.
2. Gaur D, Chitnis CE. 2011. Molecular interactions and signaling mechanisms during erythrocyte invasion by malaria parasites. Curr. Opin. Microbiol. 14:422-428. http://dx.doi.org/10.1016/j.mib.2011.07.018.
3. Gaur D, Mayer DC, Miller LH. 2004. Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int. J. Parasitol. 34:1413-1429. http://dx.doi.org/10.1016/j.ijpara.2004.10.010.
4. Cowman AF, Crabb BS. 2006. Invasion of red blood cells by malaria parasites. Cell 124:755-766. http://dx.doi.org/10.1016/j.cell.2006.02.006.
5. Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, Dubovsky F, Tucker K, Waitumbi JN, Diggs C, Wittes J, Malkin E, Leach A, Soisson LA, Milman JB, Otieno L, Holland CA, Polhemus M, Remich SA, Ockenhouse CF, Cohen J, Ballou WR, Martin SK, Angov E, Stewart VA, Lyon JA, Heppner DG, Withers MR. 2009. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS One 4:e4708. http://dx.doi.org/10.1371/journal.pone.0004708.
6. Spring MD, Cummings JF, Ockenhouse CF, Dutta S, Reidler R, Angov E, Bergmann-Leitner E, Stewart VA, Bittner S, Juompan L, Kortepeter MG, Nielsen R, Krzych U, Tierney E, Ware LA, Dowler M, Hermsen CC, Sauerwein RW, de Vlas SJ, Ofori-Anyinam O, Lanar DE, Williams JL, Kester KE, Tucker K, Shi M, Malkin E, Long C, Diggs CL, Soisson L, Dubois MC, Ballou WR, Cohen J, Heppner DG, Jr. 2009. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS One 4:e5254. http://dx.doi.org/10.1371/journal.pone.0005254.
7. Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala-Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, House B, Lanar DE, Dutta S, Heppner DG, Jr, Plowe CV. 2011. A field trial to assess a blood-stage malaria vaccine. N. Engl. J. Med. 365:1004-1013. http://dx.doi.org/10.1056/NEJMoa1008115.
8. Tham WH, Healer J, Cowman AF. 2012. Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparum. Trends Parasitol. 28:23-30. http://dx.doi.org/10.1016/j.pt.2011.10.002.
9. Cowman AF, Berry D, Baum J. 2012. The cellular and molecular basis for malaria parasite invasion of the human red blood cell. J. Cell Biol. 198: 961-971. http://dx.doi.org/10.1083/jcb.201206112.
10. Rayner JC, Vargas-Serrato E, Huber CS, Galinski MR, Barnwell JW. 2001. A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway. J. Exp. Med. 194:1571-1581. http://dx.doi.org/10.1084/jem.194.11.1571.
11. Triglia T, Duraisingh MT, Good RT, Cowman AF. 2005. Reticulocytebinding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum. Mol. Microbiol. 55:162-174. http://dx.doi.org/10.1111/j.1365-2958.2004.04388.x.
12. Rayner JC, Galinski MR, Ingravallo P, Barnwell JW. 2000. Two Plasmodium falciparum genes express merozoite proteins that are related to Plasmodium vivax and Plasmodium yoelii adhesive proteins involved in host cell selection and invasion. Proc. Natl. Acad. Sci. U.S.A. 97:9648-9653. http://dx.doi.org/10.1073/pnas.160469097.
13. Duraisingh MT, Triglia T, Ralph SA, Rayner JC, Barnwell JW, McFadden GI, Cowman AF. 2003. Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. EMBO J. 22:1047-1057. http://dx.doi.org/10.1093/emboj/cdg096.
14. Kaneko O, Mu J, Tsuboi T, Su X, Torii M. 2002. Gene structure and expression of a Plasmodium falciparum 220-kDa protein homologous to the Plasmodium vivax reticulocyte binding proteins. Mol. Biochem. Parasitol. 121:275-278. http://dx.doi.org/10.1016/S0166-6851(02)00042-7.
15. Gao X, Yeo KP, Aw SS, Kuss C, Iyer JK, Genesan S, Rajamanonmani R, Lescar J, Bozdech Z, Preiser PR. 2008. Antibodies targeting the PfRH1 binding domain inhibit invasion of Plasmodium falciparum merozoites. PLoS Pathog. 4:e1000104. http://dx.doi.org/10.1371/journal.ppat.1000104.
16. Sahar T, Reddy KS, Bharadwaj M, Pandey AK, Singh S, Chitnis CE, Gaur D. 2011. Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PLoS One 6:e17102. http://dx.doi.org/10.1371/journal.pone.0017102.
17. Triglia T, Chen L, Lopaticki S, Dekiwadia C, Riglar DT, Hodder AN, Ralph SA, Baum J, Cowman AF. 2011. Plasmodium falciparum merozoite invasion is inhibited by antibodies that target the PfRh2a and b binding domains. PLoS Pathog. 7:e1002075. http://dx.doi.org/10.1371/journal.ppat.1002075.
18. Stubbs J, Simpson KM, Triglia T, Plouffe D, Tonkin CJ, Duraisingh MT, Maier AG, Winzeler EA, Cowman AF. 2005. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science 309:1384-1387. http://dx.doi.org/10.1126/science.1115257.
19. Gaur D, Furuya T, Mu J, Jiang LB, Su XZ, Miller LH. 2006. Upregulation of expression of the reticulocyte homology gene 4 in the Plasmodium falciparum clone Dd2 is associated with a switch in the erythrocyte invasion pathway. Mol. Biochem. Parasitol. 145:205-215. http://dx.doi.org/10.1016/j.molbiopara.2005.10.004.
20. Gaur D, Singh S, Singh S, Jiang L, Diouf A, Miller LH. 2007. Recombinant Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes and blocks invasion. Proc. Natl. Acad. Sci. U.S.A. 104: 17789-17794. http://dx.doi.org/10.1073/pnas.0708772104.
21. Hayton K, Gaur D, Liu A, Henschen B, Singh S, Lambert L, Furuya T, Bouttenot R, Doll M, Nawaz F, Mu J, Jiang L, Miller LH, Wellems TE. 2008. Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe 4:40-51. http://dx.doi.org/10.1016/j.chom.2008.06.001.
22. Baum J, Chen L, Healer J, Lopaticki S, Boyle M, Triglia T, Ehlgen F, Ralph SA, Beeson JG, Cowman AF. 2009. Reticulocyte-binding protein homologue 5-an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int. J. Parasitol. 39:371-380. http://dx.doi.org/10.1016/j.ijpara.2008.10.006.
23. Hayton K, Dumoulin P, Henschen B, Liu A, Papakrivos J, Wellems TE. 2013. Various PfRH5 polymorphisms can support Plasmodium falciparum invasion into the erythrocytes of owl monkeys and rats. Mol. Biochem. Parasitol. 187:103-110. http://dx.doi.org/10.1016/j.molbiopara.2012.12.005.
24. Chen L, Lopaticki S, Riglar DT, Dekiwadia C, Uboldi AD, Tham WH, O'Neill MT, Richard D, Baum J, Ralph SA, Cowman AF. 2011. An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum. PLoS Pathog. 7:e1002199. http://dx.doi.org/10.1371/journal.ppat.1002199.
25. Crosnier C, Bustamante LY, Bartholdson SJ, Bei AK, Theron M, Uchikawa M, Mboup S, Ndir O, Kwiatkowski DP, Duraisingh MT, Rayner JC, Wright GJ. 2011. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 480:534-537.
26. Douglas AD, Williams AR, Illingworth JJ, Kamuyu G, Biswas S, Goodman AL, Wyllie DH, Crosnier C, Miura K, Wright GJ, Long CA, Osier FH, Marsh K, Turner AV, Hill AV, Draper SJ. 2011. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat. Commun. 2:601. http://dx.doi.org/10.1038/ncomms1615.
27. Bustamante LY, Bartholdson SJ, Crosnier C, Campos MG, Wanaguru M, Nguon C, Kwiatkowski DP, Wright GJ, Rayner JC. 2013. A fulllength recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants. Vaccine 31(2):373-379. http://dx.doi.org/10.1016/j.vaccine.2012.10.106.
28. Rodriguez M, Lustigman S, Montero E, Oksov Y, Lobo CA. 2008. PfRH5: a novel reticulocyte-binding family homolog of Plasmodium fal-ciparum that binds to the erythrocyte, and an investigation of its receptor. PLoS One 3(10):e3300. http://dx.doi.org/10.1371/journal.pone.0003300.
29. Pandey AK, Reddy KS, Sahar T, Gupta S, Singh H, Reddy EJ, Asad M, Siddiqui FA, Gupta P, Singh B, More KR, Mohmmed A, Chitnis CE, Chauhan VS, Gaur D. 2013. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies. Infect. Immun. 81:441-451. http://dx.doi.org/10.1128/IAI.01107-12.
30. Siddiqui FA, Dhawan S, Singh S, Singh B, Gupta P, Pandey A, Mohmmed A, Gaur D, Chitnis CE. 2013. A thrombospondin structural repeat containing rhoptry protein from Plasmodium falciparum mediates erythrocyte invasion. Cell. Microbiol. 15:1341-1356. http://dx.doi.org/10.1111/cmi.12118.
31. Sim BK, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH. 1994. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 264:1941-1944. http://dx.doi.org/10.1126/science.8009226.
32. Pandey KC, Singh S, Pattnaik P, Pillai CR, Pillai U, Lynn A, Jain SK, Chitnis CE. 2002. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol. Biochem. Parasitol. 123:23-33. http://dx.doi.org/10.1016/S0166-6851(02)00122-6.
33. Jiang L, Gaur D, Mu J, Zhou H, Long CA, Miller LH. 2011. Evidence for EBA-175 as a component of a ligand blocking blood stage malaria vaccine. Proc. Natl. Acad. Sci. U.S.A. 108:7553-7558. http://dx.doi.org/10.1073/pnas.1104050108.
34. Wickramarachchi T, Devi YS, Mohmmed A, Chauhan VS. 2008. Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion. PLoS One 3:e1732. http://dx.doi.org/10.1371/journal.pone.0001732.
35. Gaur D, Storry JR, Reid ME, Barnwell JW, Miller LH. 2003. Plasmodium falciparum is able to invade erythrocytes through a trypsin-resistant pathway independent of glycophorin B. Infect. Immun. 71:6742-6746. http://dx.doi.org/10.1128/IAI.71.12.6742-6746.2003.
36. Williams AR, Douglas AD, Miura K, Illingworth JJ, Choudhary P, Murungi LM, Furze JM, Diouf A, Miotto O, Crosnier C, Wright GJ, Kwiatkowski DP, Fairhurst RM, Long CA, Draper SJ. 2012. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens. PLoS Pathog. 8(11):e1002991. http://dx.doi.org/10.1371/journal.ppat.1002991.
37. Crompton PD, Miura K, Traore B, Kayentao K, Ongoiba A, Weiss G, Doumbo S, Doumtabe D, Kone Y, Huang CY, Doumbo OK, Miller LH, Long CA, Pierce SK. 2010. In vitro growth-inhibitory activity and malaria risk in a cohort study in Mali. Infect. Immun. 78:737-745. http://dx.doi.org/10.1128/IAI.00960-09.
38. Rono J, Färnert A, Olsson D, Osier F, Rooth I, Persson KE. 2012. Plasmodium falciparum line-dependent association of in vitro growthinhibitory activity and risk of malaria. Infect. Immun. 80:1900-1908. http://dx.doi.org/10.1128/IAI.06190-11.
39. Kennedy MC, Wang J, Zhang Y, Miles AP, Chitsaz F, Saul A, Long CA, Miller LH, Stowers AW. 2002. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 70:6948-6960. http://dx.doi.org/10.1128/IAI.70.12.6948-6960.2002.
40. Duan J, Mu J, Thera MA, Joy D, Kosakovsky Pond SL, Diemert D, Long C, Zhou H, Miura K, Ouattara A, Dolo A, Doumbo O, Su XZ, Miller L. 2008. Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design. Proc. Natl. Acad. Sci. U.S.A. 105:7857-7862. http://dx.doi.org/10.1073/pnas.0802328105.
41. Srinivasan P, Beatty WL, Diouf A, Herrera R, Ambroggio X, Moch JK, Tyler JS, Narum DL, Pierce SK, Boothroyd JC, Haynes JD, Miller LH.2011. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc. Natl. Acad. Sci. U.S.A. 108:13275-13280. http://dx.doi.org/10.1073/pnas.1110303108.
42. Lamarque M, Besteiro S, Papoin J, Roques M, Vulliez-Le Normand B, Morlon-Guyot J, Dubremetz JF, Fauquenoy S, Tomavo S, Faber BW, Kocken CH, Thomas AW, Boulanger MJ, Bentley GA, Lebrun M. 2011. The RON2-AMA1 interaction is a critical step in moving junctiondependent invasion by apicomplexan parasites. PLoS Pathog. 7(2): e1001276. http://dx.doi.org/10.1371/journal.ppat.1001276.
43. Healer J, Murphy V, Hodder AN, Masciantonio R, Gemmill AW, Anders RF, Cowman AF, Batchelor A. 2004. Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibodymediated inhibition in Plasmodium falciparum. Mol. Microbiol. 52:159-168. http://dx.doi.org/10.1111/j.1365-2958.2003.03974.x.
44. Dutta S, Lee SY, Batchelor AH, Lanar DE. 2007. Structural basis of antigenic escape of a malaria vaccine candidate. Proc. Natl. Acad. Sci. U.S.A. 104:12488-12493. http://dx.doi.org/10.1073/pnas.0701464104.
45. Ouattara A, Takala-Harrison S, Thera MA, Coulibaly D, Niangaly A, Saye R, Tolo Y, Dutta S, Heppner DG, Soisson L, Diggs CL, Vekemans J, Cohen J, Blackwelder WC, Dube T, Laurens MB, Doumbo OK, Plowe CV. 2013. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications. J. Infect. Dis. 207:511-519. http://dx.doi.org/10.1093/infdis/jis709.
46. Miura K, Herrera R, Diouf A, Zhou H, Mu J, Hu Z, MacDonald NJ, Reiter K, Nguyen V, Shimp RL, Jr, Singh K, Narum DL, Long CA, Miller LH. 2013. Overcoming allelic specificity by immunization with five allelic forms of Plasmodium falciparum apical membrane antigen 1. Infect. Immun. 81:1491-1501. http://dx.doi.org/10.1128/IAI.01414-12.
47. Duncan CJ, Hill AV, Ellis RD. 2012. Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy? Hum. Vaccin. Immunother. 8:706-714. http://dx.doi.org/10.4161/hv.19712.
48. Regules JA, Cummings JF, Ockenhouse CF. 2011. The RTS,S vaccine candidate for malaria. Expert Rev. Vaccines 10:589-599. http://dx.doi.org/10.1586/erv.11.57.
49. White NJ. 2011. A vaccine for malaria. N. Engl. J. Med. 365:1926-1927. http://dx.doi.org/10.1056/NEJMe1111777.
50. Daily JP. 2012. Malaria vaccine trials-beyond efficacy end points. N. Engl. J. Med. 367:2349-2351. http://dx.doi.org/10.1056/NEJMe1213392.
51. Stoop JW, Zegers BJ, Sander PC, Ballieux RE. 1969. Serum immunoglobulin levels in healthy children and adults. Clin. Exp. Immunol. 4:101-112.
52. Lopaticki S, Maier AG, Thompson J, Wilson DW, Tham WH, Triglia T, Gout A, Speed TP, Beeson JG, Healer J, Cowman AF. 2011. Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites. Infect. Immun. 79:1107-1117. http://dx.doi.org/10.1128/IAI.01021-10.